MacroGenics股价上涨,因吉利德支付了1000万美元的里程碑款项

路透中文
Aug 12
BUZZ-MacroGenics股价上涨,因<a href="https://laohu8.com/S/00175">吉利</a>德支付了1000万美元的里程碑款项

8月11日 - ** 药物开发商MacroGenics(MGNX.O)的股价在盘后交易中上涨3.8%,至4.07美元

** 该公司表示,根据其与吉利德(GILD.O)就一项临床前双特异性项目(一种癌症疗法)达成的许可协议,已收到1000万美元的里程碑付款

** 根据2022年签署的合作协议,MacroGenics与吉利德正在推进三个项目:处于临床阶段的抗癌疗法MGD024,以及两个处于临床前阶段的双特异性项目

** MGNX仍有资格获得最高约16亿美元的额外开发、监管及商业里程碑付款

** 今年以来,该公司股价已翻了一番多

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10